Simutomy

Mumbai, India Founded: 2022 • Age: 4 yrs
Surgical and medical training products are provided for healthcare personnel.

About Simutomy

Simutomy is a Healthcare company based in Mumbai (India) founded in 2022 by Devarshi Shah. Surgical and medical training products are provided for healthcare personnel. Simutomy has raised $30.42 thousand across 2 funding rounds from investors including SINE. The company has 1 employees. Simutomy was last valued at $756.12 thousand in May 2023. Its Indian entity Simutomy Medtech Private Limited reported revenue of β‚Ή82.1 Lakh. Simutomy offers products and services including Suture Pad, Suturing Kit, Suturing Trainer, Endotrainer, and Cyst Models. Its focus areas include HealthTech, Healthcare IT, Provider and Administrative Solutions.

Company details

Simutomy was founded in 2022 and is based in Mumbai, India. Surgical and medical training products are offered by the company to healthcare personnel within the healthcare education sector. The VisceR VR training application is provided, featuring immersive procedural learning experiences that incorporate anatomy labs, interactive quizzes, and additional educational elements. Operations focus on virtual reality-based simulations for procedural training.

Key Metrics
  • Annual Revenue
    ₹82.1 Lakh

    FY 2025 · +186% YoY

  • Net Loss
    -₹10.5 Lakh

    FY 2025 · -13% margin

  • EBITDA
    -₹8.7 Lakh

    FY 2025 · -11% margin

  • Total Equity Funding
    $30.42K (USD)

    in 2 rounds

  • Investors
  • Employee Count
    1

Products & Services of Simutomy

Simutomy offers a comprehensive portfolio of products and services, including Suture Pad, Suturing Kit, Suturing Trainer, Endotrainer, and Cyst Models.

Suture Pad
Training Tool

Device for practicing basic suturing techniques in medical training.

Suturing Kit
Training Kit

Set for hands-on surgical suturing practice and skill development.

Suturing Trainer
Simulation Device

Tool to simulate real surgical environments for professional training.

Endotrainer
Simulation Device

Product for endoscopic procedure practice in medical education.

Cyst Models
Training Model

Models for practicing cyst-related surgical procedures effectively.

Apps and channels of Simutomy

its YouTube channel Simutomy has 11.9K subscribers and 30 videos.

Simutomy
YouTube 11.9K subscribers 30 videos Education
Open channel

Videos from Simutomy

The most watched videos on Simutomy's YouTube channel, Simutomy (11.9K subscribers). Click a video to play it here.

Simutomy- Learn End-to-End Bowel Anastomosis (Type-A) #BowelAnastomosis #InstestineSuturing
438.7K views
Simutomy- Learn End-to-End Bowel Anastomosis (Type-B) #BowelAnastomosis #InstestineSuturing
34.1K views
Simutomy- Learn End-to-End Bowel Anastomosis (Type-C) #BowelAnastomosis #InstestineSuturing
29.7K views
Simutomy- Learn Side-to-Side Bowel Anastomosis (Type-D) #BowelAnastomosis #InstestineSuturing
25.7K views

More on Simutomy.

Funding Insights of Simutomy

Simutomy has successfully raised a total of $30.42K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $30,416
  • Total Rounds 2
  • First Round $30,416

    (May 2023)

  • Investors Count 1

All 2 funding rounds of Simutomy with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2024Seed––
May 2023$30,416Seed$756,117SINE
–
Valuation history

Last known valuation $756,117 (May 2023). 1 investors in total: 1 institutional.

Investors in Simutomy

Simutomy has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SINE.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
sineiitb.orgMumbai, India
Premium access

Investor details for Simutomy

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Simutomy Medtech Private Limited (Simutomy)

Simutomy Medtech Private Limited is the primary company behind Simutomy. The board of Simutomy Medtech Private Limited currently have 3 directors; the longest-serving is Devarshi Haresh Shah, appointed in 2022. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Devarshi Haresh Shah
DIN 09526151
Director03 Mar 20224 yrs 8 moSimutomy Medtech Private Limited
Nipa Haresh Shah
DIN 09643458
Director08 Jun 20224 yrs 5 moSimutomy Medtech Private Limited
Jahnvi Devarshi Shah
DIN 09526152
Director30 Sep 20242 yrs 1 moSimutomy Medtech Private Limited

People of Simutomy

1 people are tracked at Simutomy (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Founder & DirectorLeadership
Premium access

Complete people profiles for Simutomy

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Simutomy

Figures of Simutomy Medtech Private Limited, the primary company behind Simutomy, for FY 2025. Revenue was ₹82.1 Lakh (+186% year on year). Net loss was -₹10.5 Lakh (-13% margin). EBITDA was -₹8.7 Lakh (-11% margin).

  • ₹82.1 LakhRevenue · FY 2025 · +186% YoY
  • -₹10.5 LakhNet loss · -13% margin
  • -₹8.7 LakhEBITDA · -11% margin
  • ₹10,500Paid-up capital

Balance sheet, profit and loss, cash flow and ratios of Simutomy Medtech Private Limited are on its company page.

Premium access

Detailed financial statements for Simutomy

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Simutomy

3 dated milestones of Simutomy across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Simutomy is founded.
  2. Funding First funding round of $30K.
  3. Funding Latest funding round, Seed,.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Simutomy

Simutomy was founded in 2022 and raised its 1st funding round 1 year after it was founded.

Simutomy is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Simutomy is a funded company, having raised a total of $30.42K across 2 funding rounds to date. The company's 1st funding round was a Seed of $30.42K, raised on May 2023.

Simutomy has 1 employees.

The primary company behind Simutomy, Simutomy Medtech Private Limited, reported revenue of β‚Ή82.1 Lakh for FY 2025, up 186% year on year.

Simutomy was founded in 2022 and is based in Mumbai, India. Surgical and medical training products are offered by the company to healthcare personnel within the healthcare education sector. The VisceR VR training application is provided, featuring immersive procedural learning experiences that incorporate anatomy labs, interactive quizzes, and additional educational elements. Operations focus on virtual reality-based simulations for procedural training.

Simutomy offers Suture Pad, Suturing Kit, Suturing Trainer, Endotrainer, and Cyst Models.

Simutomy has 1 investor. Key investors include SINE.

The valuation of Simutomy is $756.12K as of May 2023.

Simutomy operates through Simutomy Medtech Private Limited.

The legal entities of Simutomy currently have 3 directors, including Nipa Haresh Shah, Jahnvi Devarshi Shah, Devarshi Haresh Shah.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available